Modern view on the place of riociguat in the treatment of pulmonary hypertension
Current research is aimed at studying the fundamental therapeutic targets and discovering new drugs acting on previously set targets. Until recently, the only therapeutic strategy to influence the molecular pathway of nitric oxide (NO) - soluble guanylate cyclase (sGC) - cyclic guanosine monophospha...
Main Authors: | Z S Valieva, I N Taran, T V Martynyuk, I Ye Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2018-04-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32470/pdf |
Similar Items
-
Modern view on the place of riociguat in the treatment of pulmonary hypertension
by: Z.S. Valieva, et al.
Published: (2018-04-01) -
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat
by: S. E. Gratsianskaya, et al.
Published: (2020-10-01) -
Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry
by: I E Chazova, et al.
Published: (2019-09-01) -
Treatment of patients with chronic thrombo­embolic pulmonary hypertension: focus on riociguat
by: Smith ZR, et al.
Published: (2016-06-01) -
Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
by: N. H. Kim
Published: (2010-03-01)